Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
1.020
-0.070 (-6.42%)
Dec 20, 2024, 4:00 PM EST - Market closed

Context Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Equivalents
84.814.4535.549.640.290.23
Cash & Short-Term Investments
84.814.4535.549.640.290.23
Cash Growth
291.21%-59.29%-28.48%16976.13%28.27%-
Prepaid Expenses
1.271.62.361.620.010.01
Total Current Assets
86.0716.0537.8551.260.30.24
Property, Plant & Equipment
0.260.020.08---
Long-Term Deferred Charges
----0.120.03
Other Long-Term Assets
--0.030.050.05-
Total Assets
86.3316.0637.9751.310.470.27
Accounts Payable
1.032.380.941.832.712.07
Accrued Expenses
1.111.82.131.120.960.2
Short-Term Debt
----5.8321.84
Current Portion of Long-Term Debt
----0.06-
Current Portion of Leases
0.1-0.06---
Other Current Liabilities
0.090.010.080.09--
Total Current Liabilities
2.334.193.213.039.5524.11
Long-Term Debt
----0.07-
Other Long-Term Liabilities
----0.030.13
Total Liabilities
2.474.193.213.039.6524.23
Common Stock
0.070.020.020.0200
Additional Paid-In Capital
175.2279.9178.8377.511.881.48
Retained Earnings
-91.44-68.05-44.09-29.25-18.8-25.44
Total Common Equity
83.8611.8734.7648.27-16.92-23.96
Shareholders' Equity
83.8611.8734.7648.27-9.18-23.96
Total Liabilities & Equity
86.3316.0637.9751.310.470.27
Total Debt
0.24-0.06-5.9521.84
Net Cash (Debt)
84.5614.4535.4449.64-5.66-21.62
Net Cash Growth
290.08%-59.23%-28.59%---
Net Cash Per Share
2.020.912.2217.52-2.76-
Filing Date Shares Outstanding
7515.9715.9715.970.33-
Total Common Shares Outstanding
7515.9715.9715.970.33-
Working Capital
83.7411.8634.6548.22-9.25-23.87
Book Value Per Share
1.120.742.183.02-51.00-
Tangible Book Value
83.8611.8734.7648.27-16.92-23.96
Tangible Book Value Per Share
1.120.742.183.02-51.00-
Source: S&P Capital IQ. Standard template. Financial Sources.